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T
 
he thymus is organized into discrete subcapsular, corti-
cal, and medullary environments that have been de-
fined by the distribution of morphologically and phenotyp-
ically distinct populations of epithelial cells and other
stromal cell constituents (1–5). T cell progenitor cells en-
tering the thymus move in a centripetal fashion from the
subcapsular region through the cortex to the medullary
area during their maturation process. Proximal stages of
thymocyte development thought to occur in the subcapsu-
lar and cortical compartments include expansion of the
progenitor pool and expression of pre-TCR, which in turn
 
selects thymocytes with a functional TCR-
 
b
 
 chain to un-
 
dergo further maturation and to become CD4
 
1
 
8
 
1
 
 (double
positive, DP) thymocytes expressing low levels of TCR-
 
a/b
 
.
Further development of DP thymocytes is dependent on
recognition of MHC–peptide ligands expressed by cortical
thymic epithelial cells. DP thymocytes expressing receptors
of appropriate specificity for these ligands exhibit some
phenotypic characteristics of activation and downregulate
expression of either CD4 or CD8 to yield mature CD4
 
1
 
 or
CD8
 
1
 
 single positive thymocytes (6).
Concurrent with this process of positive selection, self-
reactive thymocytes are eliminated. The anatomic setting
for this process within the thymus is variable and appears to
be dependent on the qualitative and quantitative parame-
ters of ligand expression. Extensive cortical deletion has
been observed in some TCR transgenic mouse models,
whereas in others deletion was more evident in corticomed-
ullary and medullary compartments (7). Hematogenously
derived dendritic cells localized to the inner cortex and
corticomedullary interface represent one major cell type able
to mediate clonal deletion in the thymus. Several transgenic
model systems have also pointed to a role for medullary
thymic epithelium in this process (8–10), although the ex-
tent of functional overlap of these different cell types in
their ability to mediate negative selection remains unclear.
A significant constraint on the process of thymic nega-
tive selection for a given self-protein is a requirement for
expression of the cognate peptide–MHC complex by thy-
mic APCs, either as a consequence of expression of this
particular protein by the thymic APCs or due to adequate
levels in the circulation. Although such a requirement
would be compatible with negative selection of T cells spe-
cific for some self molecules, it poses a challenge for thymic
elimination of T cells specific for self-proteins expressed in
developmentally, temporally, or spatially regulated patterns,
such as inducible tissue–specific proteins, hormones that
exhibit oscillating levels in the circulation, or proteins
whose pattern of expression are under tight developmental
control. It has been proposed that T cells reactive to such
autoantigens are inactivated in the periphery (11).
An alternative mechanism of central tolerance to one such
autoantigen is reported in this issue (12). Klein et al. exam-
ined the mechanism of CD4 T cell tolerance to C-reactive
protein, a prototype inducible serum protein produced in
the liver during acute phase reaction. In this study, mice ex-
pressing human C-reactive protein (hCRP) transgene un-
der autologous regulatory elements were crossed with two
strains of mice expressing transgenic TCRs specific for
dominant and subdominant hCRP epitopes. Based on their
initial observation of a profound deletion of CD4
 
1
 
 thy-
mocytes in these mice irrespective of hCRP serum levels,
the authors examined tissue specificity of transgene expres-
sion and found hCRP mRNA in medullary thymic epithe-
lial cells in addition to hepatocytes. The physiological rele-
vance of hCPR expression by medullary thymic epithelium
(TE) was supported by similarities in the regulation of
hCRP expression by medullary TE and hepatocytes and by
the demonstration of CRP message in human medullary
thymic epithelium and homologous acute phase proteins in
medullary thymic epithelium in mice. The demonstration
by Klein et al. that the murine homologue of human CRP
is expressed by medullary TE in a physiologically regulated
manner, together with previous studies indicating thymic
expression of a wide spectrum of molecules expressed by
other organs and tissues of ectodermal or endodermal origin,
indicate that expression of extrathymic “tissue-specific”
genes in the thymus is more prevalent than previously ap-
preciated and is of importance for the central tolerance in-
duction.
The association of numerous neuroendocrine peptides
such as vasopressin and oxytocin with thymic epithelial
cells in situ (13), and the production of some of these hor-
mones by thymic epithelial cell lines in vitro (14), has led
to the consideration of the thymus as an endocrine organ.
Additional proteins that are normally associated with other
tissues/cell types and have been localized to the thymus at
the mRNA level include insulin (15), interphotoreceptor
binding protein (16), and myelin basic protein (17), as well
as the precursor of peptide amidating enzymes necessary to
generate biologically active regulatory peptide hormones
(peptidyl-glycine a-amidating monooxygenase [PAM]; ref-
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erence 14). Because of the diversity of these “tissue-spe-
cific” molecules detected within the thymus and the obser-
vation that thymic and hepatic CRP expression appears to
be similarly regulated (12), thymic expression of these
genes may reflect a general physiological property of med-
ullary thymic epithelium. Thus, as a consequence, medul-
lary thymic epithelium displays within the thymus a mosaic
of epithelial molecules also expressed by other epithelial tis-
sues and organs.
Epithelial cells comprising the medullary compartment
exhibit considerably more morphological heterogeneity
than do their cortical counterparts. Several distinctive epi-
thelial cell types found in the medulla are depicted in Fig.
1. One subset is associated with basal laminae of major
medullary blood vessels, but continue out through the cor-
tex along connective tissue septae and are continuous with
subcapsular epithelial cells that share the basal lamina of the
thymic capsule. These cells can be identified by their reac-
tivity with the 8.1.1 mAb, which detects a 36-KD cell sur-
face molecule (18). Additional medullary epithelial subsets
ultrastructurally resemble other types of terminally differen-
tiated epithelium, including whorls of stratifying epithe-
lium reminiscent of ectodermally derived epidermal epi-
thelium (Hassal’s bodies), ciliated epithelium, similar to that
observed in proximal segments of the respiratory system
and in the reproductive system derived from endoderm
(19), and epithelial cells containing small electron-dense
vesicles resembling neurosecretory cells found in endocrine
organs and the diffuse neuroendocrine system (4). Pheno-
typic heterogeneity of medullary TE has also been well
documented, with shared antigenicity with a variety of cell
types, including keratinocytes (20), neuroendocrine cells
(21), and neural crest cells (22). Medullary epithelium has
recently been shown to express class Ib HLA-G molecules,
which are also expressed by fetal trophoblasts (23).
What is the mechanism underlying the expression of
“extrathymic” gene products by thymic epithelial cells and
how is this expression regulated? Although a generalized
derepression or “loose” transcriptional control of genes
normally expressed by differentiated epithelial cells of dif-
ferent lineages cannot be excluded, the regulated nature of
CRP expression by medullary TE as reported by Klein et al
 
.
 
(12) would argue against such a mechanism. We favor the
hypothesis that expression of these molecules reflects differ-
entiation of medullary TE along different epithelial lin-
eages. If expression of differentiated epithelial gene prod-
ucts reflects differentiation of medullary TE along different
lineage-restricted pathways, these proteins should be hetero-
geneously expressed with different gene products associated
with distinct subsets of medullary thymic epithelium. Con-
sistent with this hypothesis, thymic expression of PAM is
restricted to small scattered foci of medullary TE (14), as
are cells expressing high molecular weight keratins associ-
ated with terminally differentiated keratinocytes (24).
Expression of these molecules may represent the intrinsic
developmental potential of medullary thymic epithelium,
perhaps reflecting their embryological derivation. A wide-
 
spread distribution of endocrine cells throughout other tis-
sues and organs has become increasingly apparent with the
development of appropriate antibody and nucleic acid re-
agents, although the embryological origins of these cells,
their developmental history, and function remain poorly
understood. Another nonexclusive possibility is that local
stimuli generated within the thymus play an important role
in this process. Previous studies have demonstrated that in-
teractions between thymocytes and thymic stromal cells
control not only T cell development and selection but also
medullary epithelial cell development and the organization
of the medullary compartment. The medullary compart-
ment is present but fails to organize properly in mutant
mice unable to productively generate CD3
 
1
 
 thymocytes
(25) and is also disrupted in some lines of TCR transgenic
mice (26). One aspect of medullary epithelial development
affected by these interactions may be the generation of
medullary TE expressing phenotypic, morphologic, and/or
functional properties usually associated with other epithelial
tissues or organs. In this case, the generation of CD3
 
1
 
 T
cells required for the organization and differentiation of
medullary TE and the resulting expression of “extrathy-
mic” epithelial molecules by these cells could provide posi-
tive feedback to facilitate the clonal elimination of thy-
mocytes with reactivity to the epithelial antigens expressed
with the thymus. Circumstantial evidence that supports this
possibility is the observation that a small population of
medullary epithelial cell identified with the 10.1.1 mAb in
normal murine thymi (27) is lacking in the poorly orga-
nized medullary thymic compartment of SCID or RAG
 
2
 
/
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mice (Farr, A., unpublished observations). The high levels
of PAM expressed by 10.1.1
 
1
 
 thymic epithelial cells and
the ability of these cells to secrete an amidated peptide hor-
mone, oxytocin, which is classically associated with the hy-
pothalamohypophyseal tract (14), would indicate that these
cells represent a subset of epithelial cells that have differen-
Figure 1. Distinctive epithe-
lial components of the medullary
thymic environment. (a) Epithe-
lial cells lacking ultrastructural
features of terminally differenti-
ated epithelium and associated
with basal laminae associated
with major blood vessels in the
medulla. These cells morpholog-
ically and phenotypically resem-
ble subcapsular epithelium. (b)
Hassal’s bodies consisting of con-
centric whorls of stratified kerati-
nizing epithelium. Well devel-
oped in human thymus, they are
small and relatively sparse in the
murine thymus. (c) Ciliated columnar epithelium is often associated with
cystic structures in the medulla. Occasional cells possess large ciliated vac-
uoles. (d) Epithelial cells considered to be neuroendocrine, based on ultra-
structural similarities of small electron-dense cytoplasmic granules with
those observed in bona fide neurosecretory cells. These cells often have
distinctive cytoplasmic vacuoles with microvilli projecting into the lumen
of the vacuoles. 
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tiated along a neuroendocrine pathway. A more extensive
analysis of the cellular composition of the medullary TE in
these mutant mice should indicate the extent to which nor-
mal T cell development affects medullary expression of
“extrathymic” epithelial gene products.
Expression of the “extrathymic” gene products by thy-
mic medullary epithelium alone does not warrant presenta-
tion of peptides derived from these proteins by MHC class
II molecules. As suggested by Klein et al., secreted proteins
such as CRP can be taken up and presented by professional
APCs, namely thymic dendritic cells (12). However, cellu-
lar proteins which are not secreted or are secreted at a very
low level by thymic medullary cells are unlikely to be pre-
sented by thymic DC. Can medullary epithelial cells them-
selves induce tolerance in developing thymocytes? Experi-
ments using chimeric transgenic mice with a restricted
expression of MHC ligands in thymic medulla revealed tol-
erance induction by both deletional and nondeletional
mechanisms with a variety of different antigens (8–10).
Furthermore, medullary epithelial cell lines induced with
 
g
 
-IFN are able to process and present exogenous protein
antigens in an MHC class II–restricted fashion (28, 29). A
closer examination of the antigen-presenting properties of
medullary epithelial elements in situ and analyses of ex vivo
isolated cells revealed significant degree of heterogeneity.
Only a subset of medullary epithelial cells express MHC
class II molecules (1, 30). These cells are apparently capable
of processing and presenting at least some endogenous pro-
teins as suggested by staining with mAbs specific for a ma-
jor self peptide–MHC class II complex (31). However,
class II–positive medullary epithelial cells differ significantly
in their antigen-presenting properties as evidenced by highly
variable expression of MHC class II bound invariant chain
peptide CLIP, an essential intermediate of MHC class II
processing (31). Finally, only a subset of medullary epithe-
lial cells expresses the CD28 ligand B7 (9, 32), although the
functional significance of CD28–B7 interaction in negative
selection of thymocytes remains unclear.
Thus, thymic medullary epithelium is composed of di-
verse epithelial elements with different antigen-presenting
potential and that display a mosaic of “peripheral” self-pro-
teins. The functional importance of thymic expression of
such proteins in tolerance induction is indicated by recent
observations linking the level of expression of such autoan-
tigens in the thymus and the predisposition to related au-
toimmune diseases (16, 32, 33). Further experimentation is
needed to understand the role of specific subsets of thymic
medullary epithelial cells in establishment of the central tol-
erance to peripheral autoantigens with restricted tissue dis-
tribution or inducible expression.
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